Treataware

Treataware activities update

Graham Stocks — Mon, 06 Feb 2012 20:55:45 -0800

Treataware organises Chin Wag events and Short Courses in HIV Medicine for Community and Industry, as well producing resources and factsheets on HIV care and treatments.

An number of Treataware activities for 2012 are now in place.

New NRTI no more

Graham Stocks — Thu, 10 Jun 2010 18:42:52 -0700

Melbourne-based biotech Avexa has announced the closure of its lead HIV program for apricitabine after failing to attract a licensing partner for the Phase IIIA large clinical trial designed to establish whether a drug is effective and safe enough for widespread use. Phase III studies include expanded controlled and uncontrolled trials after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug and provide and adequate basis for physician labeling. drug.

Tales from The Network

Graham Stocks — Thu, 25 Feb 2010 21:39:43 -0800

There is a network of workers located at AIDS Councils and PLHIVPerson (or people) Living with HIV. This term is now preferred over the older PLWHA. organisations around Australasia who understand the variety of treatment issues faced by positive people. We call them the Treataware Outreach Network.

ADRIAN OGIER thought it was time we shared some of their stories.

Treataware to host two 'Chin Wags' during Mardi Gras

Graham Stocks — Wed, 27 Jan 2010 21:12:50 -0800

As part of Mardi Gras Festival celebrations this year, NAPWA's Treataware is putting on two CHIN WAG chat shows, one in the east of town, at the Cambridge Hotel in Surry Hills, and one in the west, at the Clarence, in Petersham. Positive people, their friends, partners, carers and other interested parties are all welcome.

HIV & hepatitis A, B & C

Graham Stocks — Wed, 13 Jan 2010 19:22:20 -0800

This Treataware fact sheet explains the issues for people with HIV/AIDS around coinfection with hepatitis A, B & C, including ways to minimise risk and treatment options.

New three-in-one treatment available in 2010

Adrian Ogier — Wed, 16 Dec 2009 17:00:00 -0800

From 1 January 2010 and for the cost of a single PBS[Pharmaceutical Benefits Scheme] The federal government program which subsidises medication costs in Australia. Anti-HIV drugs are part of a special part of the PBS called Section 100 (S100) which is used for expensive, highly specialised drugs. script, Australians will be able to access Atripla, the first HIV medication to combine three treatments in a single once-a-day tablet.

NAPWA’s Treataware at the 9th AIDS Impact Conference in Botswana

Graham Stocks — Mon, 19 Oct 2009 17:28:03 -0700

NAPWA’s Treataware project recently presented a poster at the 9th AIDS Impact Conference in Gaborone, Botswana.

Treataware in Port Moresby

Brent Beadle — Thu, 28 May 2009 20:15:40 -0700

NAPWA’s continuing partnership with Igat HopeOrganisation representing people living with HIV/AIDS in Papua New Guinea. ('Igat Hope' means 'There is hope' in Tok Pisin, the national language of PNG). in PNGPapua New Guinea took another leap forward with several training days addressing HIV peer education in Port Moresby on 20-21 May.

Getting the best HIV care

Wed, 06 May 2009 20:58:56 -0700

NAPWA has produced this guide to help HIV-positive Australians make the best decisions they can about their health, care and treatment.

Minimising the risk of cardiovascular disease (updated)

Brent Beadle — Wed, 25 Jun 2008 19:57:22 -0700

This Treataware fact sheet explains the current knowledge about cardiovascular (heart) disease risk in people living with HIV/AIDS, and some strategies for minimising risk.